{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-24-027629","form_type":"8-K","ticker":"ACRV","cik":"0001781174","company_name":"Acrivon Therapeutics, Inc.","filed_at":"2024-02-08T23:59:59+00:00","discovered_at":"2026-05-14T18:03:25.499147+00:00","generated_at":"2026-06-06T05:45:04.484312+00:00","sec_items":["5.02","9.01"],"event_type":"leadership","sentiment":"positive","materiality_score":0.3,"calibrated_materiality_score":0.3,"confidence":"high","headline":"Acrivon Therapeutics appoints Ivana Magovcevic-Liebisch, Ph.D., J.D., to board of directors","bullets":["Appointment effective February 8, 2024; she will receive 32,500 stock options vesting over 3 years.","Dr. Magovcevic-Liebisch is President and CEO of Vigil Neuroscience and brings 25+ years of industry experience.","She will enter into standard indemnification agreement and receive cash compensation per non-employee director policy.","No arrangements or transactions requiring disclosure under Item 404(a) exist with her selection."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-24-027629","json":"https://secwatch.observer/filing/0001193125-24-027629.json","markdown":"https://secwatch.observer/filing/0001193125-24-027629.md","text":"https://secwatch.observer/filing/0001193125-24-027629.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1781174/000119312524027629/0001193125-24-027629-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1781174/000119312524027629/d750834d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-06T05:45:04.484312+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"3efebdd313","claim":"Ivana Magovcevic-Liebisch was appointed as Director at Acrivon Therapeutics, Inc..","evidence_excerpt":"On February 7, 2024, the Board of Directors of Acrivon Therapeutics, Inc. (the “Company”) appointed Ivana Magovcevic-Liebisch, Ph.D., J.D., as a director of the Company, effective February 8, 2024.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1781174/000119312524027629/0001193125-24-027629-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}